Abstract
Palmatine and berberine, structurally similar isoquinoline alkaloids exhibiting a broad range of biological activities, were recently found to inhibit p300 histone acetyltransferase (HAT), a potential therapeutic target for treating transcriptional activator‐driven malignancies and diseases. Here, we report the first total synthesis of B‐homo palmatine (11a) and berberine (11b) derivatives, which were synthesized from 3,4‐dimethoxybenzaldehyde (1a) and benzo[d][1,3]dioxole‐5‐carbaldehyde (1b) in nine steps in 13.8 and 16.9 % overall yields, respectively. A number of other new B‐homo palmatine and berberine derivatives were also prepared. These derivatives display good inhibitory activity against p300 HAT; compound 12a manifests the most potent inhibition with an IC50 value of 0.42 µm. Cell‐based assays revealed that 12a exhibits certain inhibitory activity against HCG27, HT1080, and Z‐138 cell lines, and no visible activity towards other cancer cell lines tested, reflecting that 12a has low cytotoxicity and acts against some types of cancer cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
